Almirall is a pharmaceutical company committed to providing valuable medicines to patients worldwide. We research, develop, manufacture and market proprietary medicines as well as licensed products.
In order to make a real difference, our R&D concentrates on areas with unmet medical needs, now and in the future. We work to be leaders in respiratory and dermatology and have a significant stake in gastroenterology and pain. Our goal is to provide new and innovative medicines that improve the quality of life of patients suffering from diseases in these areas.
Key to our success is the close relationship we foster with healthcare professionals and scientists. At Almirall, we provide reliable and transparent information about our drugs and development projects, while an ongoing dialogue keeps us in touch with patients’ real needs.
Barcelona, Spain, is home to our global headquarters. Our three manufacturing plants are located in Spain and Germany. These state-of-the-art production facilities are equipped with the most advanced technology and strictly comply with international manufacturing standards (GMP). Our extensive production plant in Sant Andreu de la Barca (Barcelona, Spain) is approved by both the European Medicines Agency (EMA) and the Food and Drug Administration (FDA).
Almirall’s approach of optimistic persistence has led to continual growth since we were founded in 1943. Today, our work benefits thousands of healthcare professionals and millions of patients all over the world.
Developing innovative medicines in areas of need is what we do – but how we do it is just as important. That is why Almirall is committed to working from a foundation of respect and integrity. We understand there are many people affected by what we do. Our patients, healthcare professionals, our partners, peers and stakeholders. In a broader context, our work impacts society and the environment, too. We are firmly committed to each and everyone touched by our activities.